Previous close | 677.00 |
Open | 675.10 |
Bid | 677.80 x 30000 |
Ask | 680.50 x 30000 |
Day's range | 678.90 - 681.60 |
52-week range | 354.60 - 737.00 |
Volume | |
Avg. volume | 649 |
Market cap | 645.958B |
Beta (5Y monthly) | 0.37 |
PE ratio (TTM) | 125.26 |
EPS (TTM) | 5.42 |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | 4.75 (0.70%) |
Ex-dividend date | 14 Feb 2024 |
1y target est | N/A |
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]
Besides Wall Street's top -and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Eli Lilly, Novo Nordisk, Merck and AbbVie are part of the Zacks Industry Outlook article.